AngioDynamics Reports Fiscal 2020 First Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks rally, crude prices fall
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Crypto stocks rise premarket as Bitcoin hits over seven-month high
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- FortuneX and WT Realty announce $600M merger deal
AngioDynamics (ANGO) Tops Q1 EPS by 4c, Revenues Miss; Offers FY20 EPS Guidance Below Consensus, FY20 Mid-Point Revenue View Above Consensus
October 3, 2019 6:05 AM EDTAngioDynamics (NASDAQ: ANGO) reported Q1 EPS of $0.08, $0.04 better than the analyst estimate of $0.04. Revenue for the quarter came in at $66 million versus the consensus estimate of $67.52 million.
Fiscal 2020 First Quarter Highlights
Net sales of $66.0 million, an increase of 3.3% year over yearGross margin increased 170 basis points year over year to 57.9%GAAP loss per share of $0.03; adjusted earnings per... More